论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Huang LP, Wang GQ, Jia ZS, Chen JW, Wang G, Wang XL
Published Date July 2015 Volume 2015:11 Pages 1089—1095
DOI http://dx.doi.org/10.2147/TCRM.S82961
Received 16 February 2015, Accepted 20 May 2015, Published 27 July 2015
Approved for publication by Professor Deyun Wang
Methods: Rabbit ear models of hypertrophic scars were established to observe the therapeutic effects of paclitaxel at different concentrations (12 mg/L, 24 mg/L, 48 mg/L, 96 mg/L, 18 mg/L, 54 mg/L, 162 mg/L, 486 mg/L, 30 mg/L, 150 mg/L, 750 mg/L, 3,750 mg/L). The outcome measures included hypertrophic index (HI), density of fibroblasts, density of collagenous fibers, and microvessel density.
Results: In comparison with the control group, the concentrations of 96 mg/L, 150 mg/L, and 162 mg/L significantly reduce the formation of hypertrophic scars in the rabbit ear models. However, local necrosis was found in the rabbit ear models treated with paclitaxel solution >400 mg/L.
Conclusion: Paclitaxel has strong inhibitory effects on the hyperplasia of fibroblasts, deposition of collagen, and microangiogenesis in hypertrophic scars on rabbit ears within the concentration range from 48 mg/L to 162 mg/L, without causing local necrosis.
Keywords: hypertrophic scar, paclitaxel, rabbit ear model